Call for Abstract
Scientific Program
10th International Conference on Central Nervous System Disorders and Therapeutics, will be organized around the theme “Theme:- Clinical Advances in the Treatment of CNS Disorders”
CNS Disorders 2025 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in CNS Disorders 2025
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
The central nervous system (CNS), comprising the brain and spinal cord, is the control center of the body, regulating vital functions and enabling sensory, motor, and cognitive activities. Disorders of the CNS, such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy, disrupt its functionality, impacting health and quality of life. Advances in neuroimaging, neuropharmacology, and therapeutic interventions are revolutionizing the diagnosis and treatment of these conditions, fostering hope for improved outcomes and patient care.
Neuropsychiatric disorders encompass conditions that involve both neurological and psychiatric components, such as depression, anxiety, schizophrenia, and bipolar disorder. These disorders often result from imbalances in brain function, influenced by genetics, environment, and brain injury. Advances in neuroscience and neuropharmacology are driving progress in understanding their complex mechanisms, enabling more precise diagnostics and innovative therapies. This evolving field aims to enhance mental health care and improve the quality of life for affected individuals.
Cognitive neurology focuses on understanding how brain structures and functions relate to cognitive processes such as memory, language, attention, and problem-solving. It addresses disorders like dementia, aphasia, and traumatic brain injuries that impair cognitive abilities. Advances in neuroimaging, neuropsychology, and therapeutic interventions are enhancing diagnostic precision and treatment strategies. This field bridges neuroscience and clinical practice, aiming to preserve and restore cognitive function, improving patients' quality of life.
CNS biomarkers are measurable indicators that provide insights into the diagnosis, progression, and treatment of central nervous system disorders. These biomarkers, derived from imaging, cerebrospinal fluid, blood, or genetics, help detect conditions like Alzheimer's, multiple sclerosis, and Parkinson's at early stages. Advances in biomarker research enable precision medicine, guiding targeted therapies and monitoring treatment responses. By enhancing understanding of disease mechanisms, CNS biomarkers play a critical role in revolutionizing neurological care and improving patient outcomes.
Spinal disorders, including herniated discs, spinal stenosis, and scoliosis, can cause pain, mobility issues, and neurological impairments. Spine surgery is a specialized field aimed at alleviating these conditions through techniques like decompression, fusion, and minimally invasive procedures. Advances in surgical technology, such as robotics and navigation systems, have improved precision and outcomes. Effective treatment of spinal disorders enhances mobility, reduces pain, and significantly improves patients' quality of life.
Cerebral disorders affect the brain, impacting functions such as movement, cognition, and emotion. Conditions like stroke, epilepsy, brain tumors, and cerebral palsy fall under this category. These disorders can result from injury, genetic factors, or disease. Early diagnosis and treatment are essential for managing symptoms and preventing further damage. Advances in neuroimaging, rehabilitation, and therapeutic interventions offer hope for improving outcomes and quality of life for affected individuals.
Signal transduction in the CNS involves the transmission of chemical signals between neurons, enabling communication and regulation of brain functions. This process is critical for cognition, memory, and motor control. Disruptions in signal transduction can contribute to neurological disorders such as Alzheimer's, Parkinson's, and epilepsy. Research into signaling pathways offers insights into disease mechanisms and potential therapeutic targets, paving the way for more effective treatments for CNS disorders.
Neuronal disorders affect the functioning of neurons, the cells responsible for transmitting electrical signals in the brain and nervous system. Conditions such as Alzheimer's, Parkinson's, multiple sclerosis, and epilepsy result from neuronal degeneration or dysfunction. These disorders can cause cognitive, motor, and sensory impairments. Early diagnosis, along with advances in neuropharmacology and targeted therapies, is crucial for managing symptoms and improving the quality of life for affected individuals.
Cerebral disorders affect the brain, impacting functions such as movement, cognition, and emotion. Conditions like stroke, epilepsy, brain tumors, and cerebral palsy fall under this category. These disorders can result from injury, genetic factors, or disease. Early diagnosis and treatment are essential for managing symptoms and preventing further damage. Advances in neuroimaging, rehabilitation, and therapeutic interventions offer hope for improving outcomes and quality of life for affected individuals.
The genesis of neurons, or neurogenesis, is the process by which new neurons are formed in the brain. This occurs primarily during development but can also continue in certain brain regions like the hippocampus throughout adulthood. Neurogenesis involves the differentiation of neural stem cells into functional neurons, essential for learning, memory, and brain repair. Disruptions in neurogenesis are linked to neurological disorders such as Alzheimer's and depression.
Neurochemical transmission refers to the process by which neurons communicate with each other using neurotransmitters, chemicals that transmit signals across synapses. When an electrical impulse reaches the end of a neuron, neurotransmitters are released and bind to receptors on adjacent neurons, triggering a response. This process is crucial for brain functions such as mood regulation, learning, and motor control. Imbalances in neurochemical transmission are linked to disorders like depression and schizophrenia.
CNS and neurosurgery focus on surgical interventions for disorders of the central nervous system, including the brain and spinal cord. Neurosurgeons treat conditions like brain tumors, spinal cord injuries, epilepsy, and vascular disorders through procedures such as tumor resection, spinal fusion, and deep brain stimulation. Advances in minimally invasive techniques, neuroimaging, and robotics have enhanced surgical precision, improving patient outcomes and recovery, making neurosurgery a critical field in managing complex CNS conditions.
Pediatric neurology focuses on diagnosing and treating neurological disorders in children, including conditions like epilepsy, cerebral palsy, neurogenetic disorders, and developmental delays. Pediatric neurologists use advanced neuroimaging, genetic testing, and specialized therapies to manage these conditions. Early diagnosis and intervention are crucial for improving developmental outcomes and quality of life. Ongoing research in pediatric neurology aims to better understand the unique aspects of childhood neurological disorders and improve treatment strategies.
Neuroplasticity is the brain's ability to reorganize itself by forming new neural connections in response to learning, experience, or injury. This process allows the brain to adapt to changes, recover from damage, and optimize function. Neuroplasticity plays a key role in rehabilitation after stroke, traumatic brain injuries, and cognitive decline. Understanding and harnessing neuroplasticity offers potential for developing therapies that promote recovery and enhance brain function across the lifespan.
Neuropharmacology is the study of how drugs affect the nervous system, including the brain, spinal cord, and peripheral nerves. It explores the mechanisms of action, therapeutic effects, and potential side effects of various substances on neurological function. This field plays a crucial role in developing treatments for disorders like depression, epilepsy, Parkinson's disease, and schizophrenia. Advances in neuropharmacology aim to create more effective and targeted therapies with fewer side effects.
A set of illnesses known as neurodegenerative disorders are defined by the gradual death of neurons in the central nervous system. These disorders include, among others, Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). The primary goal of neurodegenerative disorder research is to better understand the underlying processes that cause neurodegeneration in these disorders in central nervous system. Many of these illnesses are caused by complicated combinations of many genetic and environmental variables, making it difficult to address the disease's underlying causes Notwithstanding these obstacles, neurodegenerative illness research has made substantial progress in recent years.
Computational neuroscience uses mathematical models, algorithms, and simulations to understand brain function and neural processes. By analyzing neural networks, signal processing, and brain connectivity, it aims to replicate brain activities and predict neural behaviors. This interdisciplinary field bridges neuroscience, computer science, and engineering, offering insights into cognition, perception, and disease mechanisms. Computational models are also instrumental in developing brain-computer interfaces and advancing neurotechnologies for treatment and rehabilitation.
Neurodevelopmental disorders are a group of conditions that affect the development of the nervous system, leading to challenges in cognitive, motor, and social functioning. Examples include autism spectrum disorder, ADHD, intellectual disabilities, and learning disabilities. These disorders typically manifest in early childhood and can impact behavior, communication, and learning abilities. Early diagnosis and intervention are essential for managing symptoms and supporting developmental progress, improving outcomes for affected individuals.
Keyhole brain surgery, also known as minimally invasive brain surgery, involves small incisions and the use of advanced technology like endoscopes or robotic systems to access and treat brain conditions. This technique is typically used for tumors, brain hemorrhages, or vascular malformations. Compared to traditional open surgery, keyhole surgery offers smaller scars, reduced risk of infection, quicker recovery, and less trauma to surrounding brain tissue, improving patient outcomes.
Neuroimmune Deficiency Syndrome refers to a condition where the immune system's dysfunction affects the nervous system, leading to neurological deficits. It can result from autoimmune diseases, infections, or genetic disorders that impair the body’s ability to protect the brain and spinal cord. Symptoms may include cognitive decline, motor problems, and sensory disturbances. Early detection and treatment are crucial to managing symptoms and preventing further neurological damage, often requiring immunotherapy and neurological support.
Robotic neurosurgery uses advanced robotic systems to assist surgeons in performing precise and minimally invasive procedures on the brain and spinal cord. These systems offer enhanced precision, stability, and control, reducing the risk of human error. Robotic surgery is particularly effective for complex conditions like brain tumors, vascular malformations, and epilepsy. Benefits include smaller incisions, faster recovery times, reduced complications, and improved surgical outcomes for patients.
Neuroradiology involves using advanced imaging techniques to diagnose and monitor disorders of the brain, spinal cord, and nervous system. Key diagnostic tools include MRI (Magnetic Resonance Imaging), which provides detailed images of soft tissues, and CT (Computed Tomography) scans for rapid assessment of injuries. Angiography is used to visualize blood vessels, while PET (Positron Emission Tomography) and SPECT help assess brain activity. These techniques guide diagnosis and treatment planning for neurological conditions.
Epilepsy is a neurological disorder characterized by recurrent seizures due to abnormal electrical activity in the brain. Seizures can vary in type and severity, affecting cognition, behavior, and motor skills. Treatment typically includes anti-epileptic drugs (AEDs) to control seizures, with options like surgery, vagus nerve stimulation, or a ketogenic diet used in resistant cases. Early diagnosis and tailored treatment plans are essential for managing epilepsy and improving patients' quality of life.
Neuroimmune diseases occur when the immune system mistakenly attacks the nervous system, leading to inflammation and damage. Conditions like multiple sclerosis, Guillain-Barré syndrome, and neuromyelitis optica are examples. These diseases can cause symptoms such as muscle weakness, sensory disturbances, and cognitive impairment. Treatment typically involves immunotherapy to modulate immune response, steroids to reduce inflammation, and supportive therapies to manage symptoms and improve quality of life.
Clinical trials and case reports in central nervous system (CNS) disorders are vital for advancing treatment options and improving patient care. Clinical trials assess the safety and efficacy of new therapies, including drug interventions, surgical techniques, and innovative technologies for CNS conditions like Alzheimer's, Parkinson's, and stroke. Case reports provide detailed insights into unique patient experiences, offering valuable information on rare conditions, treatment responses, and complications. Together, they contribute to the evolving knowledge of CNS disorders and their management.